Altered regulation of dopaminergic activity and impairment in motor function in rats after subchronic exposure to styrene

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 3, 2000, Pages 523-532

  Chakrabarti, Saroj K ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Dopaminergic system; Motor function; Rats; Receptor binding; Styrene; Subchronic neurotoxicity; Uptake and release

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; STYRENE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUPERSENSITIVITY;

ANIMALS; BODY WEIGHT; BRAIN; DOPAMINE; MALE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; STYRENE; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0033934590     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00216-1     Document Type: Article

References (37)

1. Agrawal A.K., Srivastava S.P., Seth P.K. Effect of styrene on dopamine receptors. Bull. Environ. Contam. Toxicol. 29:1982;400-403.
2. Arfini G., Mutti A., Vescovi P.et al. Impaired dopaminergic modulation of pituitary secretion in workers occupationally exposed to styrene. Further evidence from PRL response to TRH stimulation J. Occup. Med. 29:1987;826-830.
3. Bergamaschi E., Smargiassi A., Mutti A., Cavazzini S., Bettori M.V., Alinovi R., Franchini I., Mergler D. Peripheral markers of catecholaminergic dysfunction and symptoms of neurotoxicity among styrene-exposed workers. Int. Arch. Occup. Environ. Health. 69:1997;209-214.
4. Bond J.A. Review of the toxicology of styrene. CRC Crit. Rev. Toxicol. 19:1989;227-249.
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Calabrese G., Martini A., Sessa G., Cellini M., Bartolucci G.B., Marcuzzo G., De Rosa E. Otoneurological study in workers exposed to styrene in the fiberglass industry. Int. Arch. Occup. Environ. Health. 68:1996;219-223.
7. Claustre Y., Fage D., Zivkovic B., Scatton B. Relative selectivity of 6,7-dihydroxy-2-dimethylamino-tetralin, N-n-propyl-3-(3-hydroxyphenyl)-piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and post-synaptic dopamine receptors. J. Pharmacol. Exp. Ther. 232:1985;519-525.
8. Commissiong J.W. Monoamine metabolites. Their relationship and lack of relationship to monoaminergic neuronal activity Biochem. Pharmacol. 34:1985;1127-1131.
9. Dodd P.R., Hardy J.A., Oakley A.E., Edwardson J.A., Perry E.K., Delaunoy J.P. A rapid method for preparing synaptosomes. Comparison with alternative procedures Brain Res. 226:1981;107-118.
10. Eguchi T., Kishi R., Harabuchi I., Yuasa J., Arata Y., Katakura Y., Miyake H. Impaired color discrimination among workers exposed to styrene. Relevance of a urinary metabolite Occup. Environ. Med. 52:1995;534-538.
11. 3H-DOPA in various regions of the brain. J. Neurochem. 13:1966;655-659.
12. Gobba F., Cavalleri F., Bontadi D., Torri P., Dainese R. Peripheral neuropathy in styrene-exposed workers. Scand. J. Work Environ. Health. 21:1995;517-520.
13. Gobba F., Galassi C., Imbriani M., Ghittori S., Candela S., Cavalleri A. Acquired dyschromatopsia among styrene-exposed workers. J. Occup. Med. 33:1991;761-765.
14. Gray E.G., Whittaker V.P. The isolation of nerve ending from brain. An electron-microscopic study of cell fragments derived by homogenization and centrifugation J. Anat. 9:1962;79-88.
15. Husain R., Srivastava S.P., Mushtag M., Seth P.K. Effect of styrene on levels of serotonin, noradrenaline, dopamine and activity of acetylcholineesterase and monoamine oxidase in rat brain. Toxicol. Lett. 7:1980;47-50.
16. 3H] Mazindol-binding associated with neuronal dopamine uptake sites in corpus striatum membranes. Eur. J. Pharmacol. 90:1983;461-462.
17. Leibman K.C. Metabolism and toxicity of styrene. Environ. Health Perspect. 11:1975;115-119.
18. Lorimer W.V., Lilis R., Nicholson W.L., Anderson H., Fishbein A., Daum S., Rom W. Clinical studies of styrene workers. Initial findings Environ. Health Perspect. 17:1976;171-181.
19. Martin G.E., Williams M., Haubrich D.R. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) with selected dopamine agonists. J. Pharmacol. Exp. Ther. 223:1982;298-304.
20. Mutti A., Falzoi M., Romanelli A., Franchini I. Regional alterations of brain catecholamines by styrene exposure in rabbits. Arch. Toxicol. 55:1984;173-177.
21. Mutti A., Romanelli A., Falzoi M., Lucertini S., Franchini I. Styrene metabolism and striatal depletion in rabbits. Arch. Toxicol. 56(Suppl. 8):1985;447-450.
22. Mutti A., Franchini I. Toxicity of metabolites to dopaminergic system and the behavioral effects of organic solvents. Br. J. Ind. Med. 44:1987;721-723.
23. Pryor G.T., Rebert C.S. Interactive effects of toluene and hexane on behavior and neurophysiologic responses in Fischer-344 rats. Neurotoxicology. 13:1992;225-234.
24. Rebert C.S., Hall T.A. The neuroepidemiology of styrene. A critical review of representative literature Crit. Rev. Toxicol. 24:1994;57-106. (Suppl.).
25. Reiter L.W., Anderson G.E., Laskey J.W., Cahill D.F. Developmental and behavioral changes in the rat during chronic exposure to lead. Environ. Health Perspect. 12:1975;119-123.
26. Romanelli A., Falzoi M., Mutti A., Bergamaschi E., Franchini I. Effects of some monocyclic aromatic solvents and their metabolites on brain dopamine in rabbits. J. Appl. Toxicol. 6:1986;431-435.
27. Seegal R.F., Brosch K.O., Bush B. High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma. J. Chromatogr. 377:1986;131-144.
28. Seth P.K., Agrawal A.K., Bondy S.C. Biochemical changes in the brain consequent to dietary exposure of developing and mature rats to chlorodecone (kepone). Toxicol. Appl. Pharmacol. 59:1981;262-267.
29. Srivastava S.P., Das M., Mushtaq M., Chandra S.V., Seth P.K. Hepatic effects of orally administered styrene in rats. J. Appl. Toxicol. 2:1982;219-222.
30. Triebig G., Lehri S., Weltle D.et al. Clinical and neurobehavioral study of acute and chronic neurotoxicity of styrene. Br. J. Ind. Med. 46:1989;799-804.
31. Varner S.L., Breder C.V. Liquid chromatographic determination of residual styrene in polystyrene food packaging. J. Assoc. Off. Anal. Chem. 64:1981;647-652.
32. Walters J.R., Roth R.H. Dopaminergic neurons. An in vivo system for measuring drug interactions with presynaptic receptors Naunyn Schmiedbergs Arch. Pharmacol. 296:1976;5-14.
33. Withey J.R. Quantitative analysis of styrene monomer in polystyrene and foods including some preliminary studies of the uptake and pharmacodynamics of the monomer in rats. Environ. Health Perspect. 17:1976;125-133.
34. Withey J.R., Collins P.G. The distribution and pharmacokinetics of styrene monomer in rats by the pulmonary route. J. Environ. Pathol. Toxicol. 2:1979;1329-1342.
35. Withey J.R., Collins P.G. Pharmacokinetics and distribution of styrene monomer in rats after intravenous administration. J. Toxicol. Environ. Health. 3:1977;1011-1020.
36. Yuasa J., Kishi R., Eguchi T., Harabuchi I., Katakura Y., Imai T., Matsumoto H., Yokogama H., Miyake H. Study of urinary mandelic acid concentration and peripheral nerve conduction among styrene workers. Am. J. Ind. Med. 30:1996;41-47.
37. Zaidi N.F., Agrawal A.K., Srivastava S.P., Seth P.K. Effect of styrene oxide on dopamine receptors in rats. Bull. Environ. Contam. Toxicol. 35:1985;602-607.